View filings sent in on a given day. This is not the same as the event date of the transaction triggering the filing. To see all 13D/G filings ordered by event date, use the 13D/G Search Page instead.
Event Date | Filed By | Subject Company | Ticker | Total Reported Shares |
13F Reported Shares for Q4 2023 | % Ownership | Previous transaction | 13D Reason | |||
---|---|---|---|---|---|---|---|---|---|---|---|
03/18/2024 | SC 13D/A | Backtest | CLS THERAPEUTICS, LLC | Xenetic Biosciences Inc | XBIO | 215,964 | 14.00% | SC 13D/A Filing on 2023-09-05: 198,888 shares reported | Reason | ||
03/18/2024 | SC 13G | Backtest | COVE STREET CAPITAL, LLC | TruBridge Inc. | TBRG | 733,379 | 5.06% | ||||
03/18/2024 | SC 13D/A | Backtest | TOLIA NIRAV N | Nextdoor Holdings Inc | KIND | 29,356,246 | 13.20% | SC 13D Filing on 2021-11-05: 24,185,323 shares reported | |||
03/18/2024 | SC 13G | Backtest | CITADEL ADVISORS LLC | Atara Biotherapeutics Inc | ATRA | 6,533,119 | 263,051 | 6.40% | 13F Filing on 2023-12-31: 263,051 shares reported | ||
03/18/2024 | SC 13G | Backtest | ARNO ANDREW | Creatd Inc | VOCL | 72,810 | 7.34% | ||||
03/18/2024 | SC 13D/A | Backtest | ICAHN CARL C | CVR Energy Inc | CVI | 66,692,381 | 66,692,381 | 66.30% | 13F Filing on 2023-12-31: 66,692,381 shares reported | Reason | |
03/18/2024 | SC 13G/A | Backtest | TOPLINE CAPITAL MANAGEMENT, LLC | Issuer Direct Corp | ISDR | 556,061 | 14.50% | SC 13G Filing on 2024-02-08: 248,791 shares reported | |||
03/18/2024 | SC 13D | Backtest | ICAHN CARL C | CVR PARTNERS LP | UAN | 3,892,000 | 36.80% | Reason | |||
03/18/2024 | SC 13D/A | Backtest | PINETREE CAPITAL LTD. | TruBridge Inc. | TBRG | 1,901,200 | 9.70% | SC 13D Filing on 2024-03-12: 1,594,000 shares reported | |||
03/15/2024 | SC 13D/A | Backtest | SABA CAPITAL MANAGEMENT, L.P. | BNY Mellon Strategic Municipal Bond Fund, Inc. | DSM | 3,081,229 | 2,518,798 | 6.23% | 13F Filing on 2023-12-31: 2,518,798 shares reported | ||
03/15/2024 | SC 13D/A | Backtest | JAB BEVCO B.V. | Keurig Dr Pepper Inc | KDP | 283,443,879 | 21.00% | SC 13D/A Filing on 2024-03-08: 296,487,357 shares reported | Reason | ||
03/14/2024 | SC 13D/A | Backtest | CAS INVESTMENT PARTNERS, LLC | Cardlytics Inc | CDLX | 6,023,676 | 5,416,116 | 13.70% | 13F Filing on 2023-12-31: 5,416,116 shares reported | ||
03/14/2024 | SC 13D/A | Backtest | CORVEX MANAGEMENT LP | MDU Resources Group | MDU | 10,147,041 | 10,147,041 | 4.98% | 13F Filing on 2023-12-31: 10,147,041 shares reported | Reason | |
03/14/2024 | SC 13D/A | Backtest | CANO HEALTH, INC. | MSP Recovery Inc | LIFW | 2,308,360 | 15.60% | SC 13D/A Filing on 2024-03-07: 2,549,190 shares reported | |||
03/14/2024 | SC 13D/A | Backtest | RA CAPITAL MANAGEMENT, L.P. | Eliem Therapeutics Inc | ELYM | 13,179,181 | 13,150,849 | 47.50% | 13F Filing on 2023-12-31: 13,150,849 shares reported | Reason | |
03/14/2024 | SC 13D/A | Backtest | GROWTH EQUITY OPPORTUNITIES V, LLC | Regulus Therapeutics Inc | RGLS | 6,533,102 | 9.99% | SC 13D/A Filing on 2023-04-13: 1,945,579 shares reported | Reason | ||
03/14/2024 | SC 13D/A | NEW MOUNTAIN GUARDIAN INVESTMENTS IV, L.L.C. | NEW MOUNTAIN GUARDIAN IV BDC, L.L.C. | 4,500,000 | 12.30% | Reason | |||||
03/14/2024 | SC 13D/A | NEW MOUNTAIN GUARDIAN IV RATED FEEDER I, LTD | NEW MOUNTAIN GUARDIAN IV BDC, L.L.C. | 14,850,000 | 40.40% | Reason | |||||
03/14/2024 | SC 13D/A | Backtest | FS CAPITAL PARTNERS VI, LLC | Arhaus Inc | ARHS | 250,000 | 12,277,543 | 0.47% | 13F Filing on 2023-12-31: 12,277,543 shares reported | Reason | |
03/14/2024 | SC 13D/A | Backtest | NOVO HOLDINGS A | Spruce Biosciences, Inc. | SPRB | 6,466,021 | 6,722,336 | 15.10% | 13F Filing on 2023-12-31: 6,722,336 shares reported | ||
Display limit of 20 for non-subscribers. A subscription is required to see all 13D/G filings |